MarketInOut Stock Screener Log In | Sign Up

Molbio Diagnostics Ltd

Healthcare • Medical Devices • Quote as of 10/28/2026 15:56
Molbio Diagnostics Ltd stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
Market Capitalization148,060 mln
Float32.19 mln

EPS

14.46
Stretched

P / E

90.78
Speculative

1-Year Forecast

1,650.00
Strong upside

Relative Strength

18 / 100
Significantly lagging

Debt / Equity

0.15
Very low leverage

Pre-Tax Margin

19%
Healthy margin

Business Description

Molbio Diagnostics Limited, founded in 2000 and headquartered in Verna, India, develops and sells medical testing tools designed to identify a wide range of infectious and chronic diseases at the point of care. The company's product lineup includes portable testing machines, rapid disposable test kits for conditions such as dengue, malaria, and COVID-19, as well as its flagship Truenat platform, which uses real-time molecular technology to support treatment decisions for diseases including tuberculosis, HIV, hepatitis, and several others. Molbio also produces diagnostic chips, reagents, and X-ray equipment, making it a broad supplier of frontline healthcare solutions.

Key Fundamentals

EPS14.46
P/E90.78
ROE16.42
RPS156
ROIC14.19
ROA10.96
Interest Cover12.40
EBITDA, mln2,586
EV / EBITDA56.02
EV / EBIT67.68
Revenue, mln10,204
EV / Revenue14.20

Quote Details

Last 1,312.70
Change 46.9 (3.71%)
Open 1,266.00
Volume 775,947
Turnover 1,018,585,600
Average Volume 1,886,390

Financial Ratios

Pre-Tax Profit Margin19
Current Ratio2.11
Price / Book16.96
Price / Tangible Book18.01
Price / Free Cash Flow73.40
Debt / Equity0.15
Price / Sales16.07

Financial Strength

Price to Graham Number9.46
1-Year Target Price1,650.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.75% 57 / 100   
1 Month 5.35% 91 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog